QT Vascular assures investors over suit

Singapore

QT VASCULAR has assured investors in an update on the ongoing litigation involving specialty balloon angioplasty company AngioScore Inc during its annual general meeting on Thursday last week.

In June 2012, AngioScore initiated patent infringement proceedings against QT subsidiaries TriReme Medical and Quattro Vascular, as well as QT Vascular's chief executive Eitan Konstantino in relation to the Chocolate PTA balloon catheter. AngioScore's claim is that QT Vascular's Chocolate PTA infringes the '119 Patent - a patent…